Condition: Inflammatory Bowel Disease (IBD) · Medication Compliance · Quality of Life · Sponsor: Istanbul University - Cerrahpasa
This randomized controlled trial aims to evaluate the effect of nurse-led telehealth monitoring on medication adherence, self-efficacy, and quality of life in individuals with inflammatory bowel disease (IBD). The study will be conducted at the IBD Outpatient Clinic of Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty. Participants will be randomly assigned to either an intervention group receiving a 3-month structured telehealth program (including education, counseling, phone calls, and reminders) or a control group receiving only standard care and an educational booklet. Outcomes will be assessed at baseline and after 12 weeks.
This description comes directly from the study's public registry record.
Kimya Kılıçaslan, PhD Candidate · +90 535 083 45 53 · kimya.kilicaslan@iuc.edu.tr
Zeliha Tulek, PhD, Prof. · +90 532 776 29 93 · ztulek@iuc.edu.tr
Always discuss trial participation with your own doctor first.
| Istanbul University - Cerrahpasa Cerrahpaşa Faculty of Medicine Department of Gastroenterology | Istanbul, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06971627